Search
You have executed a tag search on The Deal Pipeline. Below, you will find a comprehensive list of stories tagged "Pfizer Inc.."
12 result(s) displayed (1 - 12 of 37)
The transaction, worth up to $1.85 billion, is the third-largest acquisition of an Indian pharmaceuticals company to date. Continue reading
Posted on February 28, 2013 8:12 AM
Often mentioned as a takeover candidate, the CEO of the company with a vibrant oncology drug pipeline tells those gathered at the BIO CEO & Investor Conference that it may become an acquirer. Continue reading
Posted on February 12, 2013 3:43 PM
Pfizer's former animal health business fetches a $13 billion valuation as it prices above its target range. Continue reading
Posted on February 1, 2013 4:59 PM
The animal health business expects to price its IPO at $22 to $25 per share and raise roughly $2.2 billion. Continue reading
Posted on January 18, 2013 12:01 PM
Mitsubishi Chemical pays $654 million for the maker of pharmaceutical capsules. Continue reading
Posted on December 26, 2012 11:47 AM
The U.K. group offers $1.4 billion for the Salt Lake City company as it seeks to establish a vitamin and nutrition business. Continue reading
Posted on November 16, 2012 9:14 AM
The maker of central nervous system therapies forms a strategic alliance with Moksha8 Pharmaceuticals that could ultimately lead to a buyout of the São Paulo-based drugmaker. Continue reading
Posted on October 24, 2012 2:12 PM
Pfizer has made a $250 million move to bolster its consumer healthcare division through an agreement with AstraZeneca that could begin a larger relationship between the drugmakers Continue reading
Posted on August 15, 2012 4:33 PM
The pharmaceutical company's share price is buoyed by takeover speculation after its Alzheimer's compound fails a clinical trial Continue reading
Posted on August 8, 2012 9:08 AM
When the bell finally rang on the long-awaited divestiture of Pfizer Inc.'s nutrition business early Monday, April 23, the only thing that surprised observers was the high price tag. But what investors will likely watch with greater curiosity is where... Continue reading
Posted on April 24, 2012 9:57 AM
Nestlé triumphs over Danone with a bid valuing the business at 19.8 times forecast Ebitda Continue reading
Posted on April 23, 2012 10:28 AM
A sale of the nutrition business could be announced as soon as next week. Continue reading
Posted on April 18, 2012 12:46 PM
Movable Type search results powered by Fast Search
Ken deRegt will retire as head of fixed income at Morgan Stanley and be replaced by Michael Heaney and Robert Rooney. For other updates launch today's Movers & shakers slideshow.
Apax Partners offers $1.1 billion for Rue21, the same teenage fashion chain it took public in 2009. More video
